Economy

Economy
Economy

Evening digest: Anthropic to target $2T valuation in IPO, Gold slips

Anthropic is reportedly targeting a valuation of at least $2 trillion in a potential October IPO, while Chinese memory-chip maker CXMT has overtaken Tencent to become the country’s most valuable listed company. Gold prices retreated from two-month highs as investors booked profits after fresh US inflation data, and oil pared steep losses after reports of

Read More
Economy

Dow rises as S&P 500 closes at record high on softer inflation, tech gains

US stocks ended higher on Thursday, with the S&P 500 closing at a fresh record as easing inflation data, falling oil prices and continued strength in technology shares lifted investor sentiment. The S&P 500 rose 0.66% to close at 7,799.73 after briefly crossing the 7,800 mark for the first time during the session. The Nasdaq

Read More
Economy

Zeta Global stock slips after earnings: Is it safe to buy the dip now?

Zeta Global stock pared back some of its gains from earlier this week as investors booked profits following its earnings report. It retreated to $23 from this week’s high of $24.45. It remains about 65% above the lowest level this year, giving it a market capitalization of over $6 billion.  Zeta Global stock dropped despite

Read More
Economy

Oracle stock is rebounding despite the soaring CDS spread: is it a buy?

Oracle stock has rebounded in the past few days as investors have rotated to technology names as the earnings season gains steam. ORCL jumped to $145 on  Tuesday, up by 27% from its lowest level this year. So, is the stock a good buy as its CDS spread jumps to a record high? Oracle’s CDS

Read More
Economy

ADP report: US private employers added 44,000 in July, well below forecasts

Hiring at US private companies slowed sharply in July, with healthcare accounting for the bulk of new jobs as employers adopted a more cautious approach to recruitment amid shifting economic conditions. According to payroll processing firm ADP, private nonfarm employment rose by a seasonally adjusted 44,000 jobs during the month, falling well short of economists’

Read More
Economy

Dow rises as SpaceX, AMD slide despite earnings, Iran hopes lift stocks

US stocks opened higher on Wednesday as investors balanced optimism over a potential diplomatic breakthrough in the Middle East against disappointing market reactions to earnings from SpaceX and Advanced Micro Devices (AMD). The Dow Jones Industrial Average rose about 0.76%, while the S&P 500 gained 0.59%. The Nasdaq Composite added roughly 0.41%, following a strong

Read More
Economy

Cisco is the best-performing Dow Jones stock this year: here’s why and what’s next

Cisco Systems stock is in a strong bull run this year and is the best-performing company in the Dow Jones Index. It has jumped by 60%, beating other top companies like Caterpillar, Travelers, Chevron, and Coca-Cola. This surge happened as the company became a major provider of AI infrastructure solutions. Cisco Systems’ business is booming

Read More
Economy

NYT stock drops 12% as it added fewer than expected digital subscribers in Q2

The New York Times NYT shares fell more than 12% in trading on Wednesday after the publisher reported slower-than-expected digital subscriber growth for the second quarter and issued a weaker-than-anticipated outlook for digital subscription revenue. The media company added about 280,000 net digital-only subscribers during the quarter, below analysts’ average estimate of 295,300 compiled by

Read More
Economy

Why Nvidia stock is soaring over 4% today

Nvidia stock (NVDA) rose sharply on Wednesday after Elon Musk said SpaceX would build its artificial intelligence infrastructure exclusively around Nvidia’s processors. The stock climbed 4.6% to about $221 in early trading. The gains also came as rival Advanced Micro Devices looked set for a weaker session, with its shares falling more than 5% in

Read More
Economy

Eli Lilly stock surges 6% after Q2 earnings beat driven by Mounjaro, Zepbound

Eli Lilly stock LLY gained 6% on Wednesday after delivering a stronger-than-expected second quarter as robust demand for its blockbuster GLP-1 medicines Mounjaro and Zepbound lifted revenue and profit well above Wall Street expectations. This has prompted the drugmaker to raise its full-year revenue outlook. The company reported adjusted earnings per share of $8.38, comfortably

Read More